PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels.

BACKGROUND AND PURPOSE:The Kv β1.3 subunit modifies the gating and pharmacology of Kv 1.5 channels in a manner, decreasing channel sensitivity to bupivacaine- and quinidine-mediated blockade. Cardiac Kv 1.5 channels associate with receptor for activated C kinase 1 (RACK1), the Kv β1.3 subunit and different isoforms, resulting in the formation of a functional channelosome. The aim of the present study was to investigate the effects of duanyu1531 inhibition on bupivacaine and quinidine block of Kv 1.5 + Kv β1.3 channels. EXPERIMENTAL APPROACH:HEK293 cells were transfected with Kv 1.5 + Kv β1.3 channels, and currents were recorded using the whole-cell configuration of the patch-clamp technique. duanyu1531 inhibition was achieved by incubating the cells with either calphostin C or bisindolylmaleimide II and the effects of bupivacaine and quinidine were analysed. KEY RESULTS:The voltage-dependent inactivation of Kv 1.5 + Kv β1.3 channels and their pharmacological behaviour after duanyu1531 inhibition with calphostin C were similar to those displayed by Kv 1.5 channels alone. Indeed, the IC50 values for bupivacaine were similar in cells whose duanyu1531 was inhibited with calphostin C or bisindolylmaleimide II. Similar results were also observed in the presence of quinidine. CONCLUSIONS AND IMPLICATIONS:The finding that the voltage-dependence of inactivation and the pharmacology of Kv 1.5 + Kv β1.3 channels after duanyu1531 inhibition resembled that observed in Kv 1.5 channels suggests that both processes are dependent on phosphorylation. These results may have clinical relevance in diseases that are characterized by alterations in kinase activity.

KEYWORDS: {{ getKeywords(articleDetailText.words) }}